BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs7903146
,
FGF21
,
Fatty acid metabolic process
,
Diabetes mellitus
,
Kidney
,
Prozac
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
peptides P4
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Whole blood of IRAK4-null, MYD88-null and normal donors treated with Toll-like receptor agonists
Myometrial cells cultured and treated with IL-1beta and/or progesterone
Corpus lutea from hCG treated macaques depleted of steroids
Progesterone-regulated genes in immune cells: Regulation of T cell genes by progesterone
Ovaries from post-natal day 4 rats cultured with neutrophin 3
Explore Curated Studies Results
Literature
Most Relevant Literature
Parasiticidal activity of Haemaphysalis longicornis longicin P4 peptide against Toxoplasma gondii.
Release of hydrophobic anticancer drug from a newly designed self-assembling peptide.
Inflammation-induced shift in spinal GABA(A) signaling is associated with a tyrosine kinase-dependen…
Enrichment of antioxidant peptide from rice protein hydrolysates via rice husk derived biochar.
Immunotherapy with a combination of intravenous immune globulin and p4 peptide rescues mice from pos…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
P4 Peptide in Community Acquired Pneumonia
Melanoma Vaccine With Peptides and Leuprolide
Peptide Vaccination for Patients at High Risk for Recurrent Melanoma
Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patient…
Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk Melanoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ